Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Satyamitra Kemas Lestari Tbk. (SMKL) Price & Performance

UBC Medical Indonesia Tbk.Trade
Satyamitra Kemas Lestari Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Satyamitra Kemas Lestari Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Satyamitra Kemas Lestari Tbk. trades at Rp135 (market cap 475.11B, 11.2M 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and Satyamitra Kemas Lestari Tbk. is more actively traded (11.2M versus 3.48M). Which is the better fit depends on your goals.

LABSSMKL
Market Cap
576.7B475.11B
Volume
3.48M11.2M
Lot
34.82K112K
Turnover
522.79M1.69B
Average Price
150.13151.01
Value
522.79M1.69B
Indicative Equilibrium Price
148135
Indicative Equilibrium Volume
35050

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
SMKL
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Satyamitra Kemas Lestari Tbk.

PT Satyamitra Kemas Lestari Tbk (The Company) was established based on Deed of Establishment No. 12 dated July 26, 2001 which was made in the presence of Juniaty Tedjaputra, S.H., a notary in Tangerang.

Read more on SMKL